Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05631405 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2025 to Nov 1, 2026
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v4
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v3
  3. Interventions: Dexamethasone (Drug) to Dexamethasone (Drug), Placebo (Drug)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.
Trial Details
NCT Number NCT05631405
Lead Sponsor Chulalongkorn University
Conditions
(from sponsor)		 Severe Dengue
Related terms Severe Dengue
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov